β-catenin and cyclin D1 in mucoepidermoid carcinoma of variable histologic grades

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 8, 2005, Pages 701-706

  Da Costa Miguel, Márcia Cristina ^a   Campos Oliveira, Márcio ^a,b   Guerra Seabra, Flávio Roberto ^a   Guedes Queiroz, Lélia Maria ^a   De Almeida Freitas, Roseana ^a   De Souza, Lélia Batista ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1;

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER GRADING; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; FISHER EXACT TEST; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RESEARCH; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, MUCOEPIDERMOID; CHILD; CYCLIN D1; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; STAINING AND LABELING; STATISTICS, NONPARAMETRIC; TRANS-ACTIVATORS;

EID: 23944450200     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.8.701     Document Type: Article

References (35)

1. Ellis GL, Auclair PL. Tumours of the salivary glands. In: Atlas of Tumor Pathology. 3rd series, fascicle 17. Washington, DC: Armed Forces Institute of Pathology; 1996:155-175.
2. Dardick I. Color Atlas/Text of Salivary Gland Pathology. New York, NY: Igaku-Shoin Medical Publishers; 1996.
3. Shieh YS, Chang LC, Chiu KC, Wu CW, Lee HS. Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome. J Oral Pathol Med. 2003;32:297-304.
4. Pires FR, Almeida OP, Araújo VC, Kowalski LP. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:174-180.
5. Perez-Ordonez B. Selected topics in salivary gland tumour pathology. Curr Diagn Pathol. 2003;9:355-365.
6. Natsume H, Sasaki S, Kitagawa M, et al. β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochem Biophys Res Commun. 2003;309:408-413.
7. Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol. 1999;35:333-342.
8. Rousseau A, Lim MS, Lin Z, Jordan RC. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol. 2001;37:268-275.
9. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lopez-Arranz JS. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol. 2002;38:301-308.
10. Haas S, Hormann K, Bosch FX. Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use. Oral Oncol. 2002;38:618-623.
11. Howng SL, Wu CH, Cheng TS, et al. Differential expression of Wnt genes, β-catenin and E-cadherin in human brain tumors. Cancer Lett. 2002;183:95-101.
12. Lopez-Gonzalez JS, Cristerna-Sanchez L, Vazquez-Manriquez ME, Jimenez-Orci G, Aguilar-Cazares D. Localization and level of expression of beta-catenin in human laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2004;130:89-93.
13. Wheelock MJ, Johnson KR. Cadherin-mediated cellular signaling. Curr Opin Cell Biol. 2003;15:509-514.
14. Hicks MJ, el-Naggar AK, Flaitz CM, Luna MA, Batsakis JG. Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation. Head Neck. 1995;17:89-95.
15. Oloumi A, McPhee T, Dedhar S. Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta. 2004;1691:1-15.
16. Ben-Ze'ev A, Shtutman M, Zhurinsky J. The integration of cell adhesion with gene expression: the role of β-catenin. Exp Cell Res. 2000;261:75-82.
17. Seidler HB, Utsuyama M, Nagaoka S, Takemura T, Kitagawa M, Hirokawa K. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups. Exp Mol Pathol. 2004;76:224-233.
18. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 2001;61:8247-8255.
19. Lee CM, Shvartsman H, Deavers MT, et al. β-Catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol. 2003;88:363-368.
20. Williams HK, Sanders DS, Jankowski JA, Landini G, Brown AM. Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med. 1998;27:308-317.
21. Lo Muzio L, Staibano S, Pannone G, et al. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res. 1999;19:3817-3826.
22. Yokoyama K, Kamata N, Hayashi E, et al. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol. 2001;37:65-71.
23. Bankfalvi A, Krassort M, Vegh A, Felszeghy E, Piffko J. Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med. 2002;31:450-457.
24. Nigg EA. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays. 1995;17:471-480.
25. Cordon-Cardo C. Mutations of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol. 1995;147:545-560.
26. Si X, Liu Z. Expression and significance of cell cycle-related proteins Cyclin D1, CDK4, p27, E2F-1 and Ets-1 in chondrosarcoma of the jaws. Oral Oncol. 2001;37:431-436.
27. Etges A, Nunes FD, Ribeiro KC, Araujo VC. Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol. 2004;40:326-331.
28. Perez-Ordonez B, Linkov I, Huvos AG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation. Histopathology. 1998;32:521-529.
29. Shintani S, Ohyama H, Zhang X, et al. p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein. Mol Cell Biol. 2000;20:6300-6307.
30. Michalides RJ, van Veelen NM, Kristel PM, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1997;123:497-502.
31. Mineta H, Miura K, Takebayashi S, et al. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol. 2000;36:194-198.
32. Meredith SD, Levine PA, Burns JA, et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma: association with poor prognosis. Arch Otolaryngol Head Neck Surg. 1995;121:790-794.
33. Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer. 1997;74:576-581.
34. Nogueira CP, Dolan RW, Gooey J, et al. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope. 1998;108:345-350.
35. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96:5522-5527.